Targeting Blood Sugar To Near-normal Levels Increases Risk Of Death In Persons With Diabetes At High Risk, ACCORD Trial Shows
Friday, June 6, 2008 - 17:21
in Health & Medicine
Intensively targeting blood sugar to near-normal levels in adults with type 2 diabetes at especially high risk for heart attack and stroke does not significantly reduce the risk of major cardiovascular events, such as fatal or nonfatal heart attacks or stroke, but increases risk of death, compared to standard treatment.
Read the whole article on Science Daily
More from Science Daily
Related
- ACCORD clinical trial publishes resultsFri, 6 Jun 2008, 17:35:45 EDT
- Diabetics' heart attack risk can be reduced, research findsThu, 21 May 2009, 19:36:37 EDT
- Common COPD medications linked with increased risk of CV death, heart attackTue, 23 Sep 2008, 16:43:40 EDT
- Similar long-term mortality risks in men with type 2 diabetes and men with cardiovascular diseaseMon, 5 Jan 2009, 17:49:56 EST
- Invasive treatment appears beneficial for men and high-risk women with certain coronary syndromesWed, 2 Jul 2008, 10:07:48 EDT